Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

Abstract Non-alcoholic steatohepatitis (NASH) is a major health problem leading to liver fibrosis and hepatocellular carcinoma, among other diseases, and for which there is still no approved drug treatment. Previous studies in animal models and in LX-2 cells have indicated a role for serotonin (5-HT...

Полное описание

Библиографические подробности
Главные авторы:	Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling, Magnus Ingelman-Sundberg
Формат:	Статья
Язык:	English
Опубликовано:	Nature Portfolio 2024-01-01
Серии:	Scientific Reports
Online-ссылка:	https://doi.org/10.1038/s41598-023-49240-9

Схожие документы

The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
по: Sara Redenšek Trampuž, и др.
Опубликовано: (2023-01-01)

The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model
по: Sander van Riet, и др.
Опубликовано: (2024-03-01)

Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
по: Tracey Hurrell, и др.
Опубликовано: (2020-04-01)

Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
по: Chris S. Pridgeon, и др.
Опубликовано: (2022-05-01)

Azologization of serotonin 5-HT3 receptor antagonists
по: Karin Rustler, и др.
Опубликовано: (2019-03-01)

Existence of Brain 5‑HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5‑HT1A Receptor Recognition
по: Dasiel O. Borroto-Escuela, и др.
Опубликовано: (2017-08-01)

Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury
по: Mitsuhiro Goda, и др.
Опубликовано: (2021-09-01)

How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties?
по: Abbas Norouzi, и др.
Опубликовано: (2012-04-01)

How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties?
по: Reza Rahimian, и др.
Опубликовано: (2012-04-01)

Constitutively active 5-HT receptors: An explanation of how 5-HT antagonists inhibit gut motility in species where 5-HT is not a enteric neurotransmitter ?
по: Nick eSpencer
Опубликовано: (2015-12-01)

Antiemetic Activity of FK1052, a 5-HT3- and 5-HT4-Receptor Antagonist, in Suncus murinus and Ferrets
по: Hiroe Nakayama, и др.
Опубликовано: (2005-01-01)

Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor
по: Habib Abul Muntasir, и др.
Опубликовано: (2006-01-01)

5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra.
по: Threlfell, S, и др.
Опубликовано: (2010)

The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.
по: Roberts, J, и др.
Опубликовано: (2002)

THE ANTIEMETIC ACTION OF THE NOVEL 5-HT3 RECEPTOR ANTAGONIST L-683,877 IN THE FERRET
по: Tattersall, F, и др.
Опубликовано: (1990)

ANTAGONIST EFFECT OF MDL-73005EF ON POSTSYNAPTIC 5-HT1A RECEPTORS IN THE RAT
по: Gartside, S, и др.
Опубликовано: (1990)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
по: Boothman, L, и др.
Опубликовано: (2006)

Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists
по: Heng, Hui Li, и др.
Опубликовано: (2018)

Automated Synthesis of 5-HT1A Receptors Antagonists 11C-WAY-100635
по: LI Hui-qiang1,2;ZHEN Zhi-fei1;ZHANG Wei-feng1;LIAO Shu-guang1;LI Hong-li3;XU Jun-ling1,2
Опубликовано: (2017-02-01)

3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists
по: Antonijević Mirjana, и др.
Опубликовано: (2017-01-01)

Serotonin (5-HT3) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
по: Itagaki R, и др.
Опубликовано: (2014-03-01)

Combination of Direct DNA Sequencing with Degenerate Primer-Mediated PCR and 5′-/3′-RACE to Screen Novel cDNA Sequences
по: Che Fang, и др.
Опубликовано: (1997-07-01)

Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress
по: Hyun Young Kim, и др.
Опубликовано: (2024-06-01)

Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
по: Corbett, D, и др.
Опубликовано: (2005)

The Human Cytochrome P450 (<it>CYP</it>) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
по: Sim Sarah C, и др.
Опубликовано: (2010-04-01)

Intronic polymorphisms of cytochromes P450
по: Ingelman-Sundberg Magnus, и др.
Опубликовано: (2010-08-01)

Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
по: Hughes, Z, и др.
Опубликовано: (2007)

Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.
по: Humphrey, P, и др.
Опубликовано: (1999)

Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
по: Sharpley, A, и др.
Опубликовано: (1990)

Design of an innovative nanovehicle to enhance brain permeability of a novel 5-HT6 receptor antagonist
по: María Javiera Alvarez-Figueroa, и др.
Опубликовано: (2024-12-01)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
по: Tijana Bojić, и др.
Опубликовано: (2022-04-01)

Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation
по: Gonzalo Vera, и др.
Опубликовано: (2016-08-01)

5-HT3-Receptor Antagonist Inhibits Visceral Pain Differently in Chemical and Mechanical Stimuli in Rats
по: Tomohisa Mori, и др.
Опубликовано: (2004-01-01)

Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.
по: Gerhard Rammes, и др.
Опубликовано: (2009-08-01)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
по: Karolina Pytka, и др.
Опубликовано: (2015-01-01)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
по: Tiong Cheng Sia, и др.
Опубликовано: (2013-08-01)

Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
по: Castro, E, и др.
Опубликовано: (2003)

A possible role for 5-HT2C receptors in postsynaptic feedback regulation of 5 HT neurones
по: Raley, J, и др.
Опубликовано: (2006)

Pharmacophore based synthesis of 3-chloroquinoxaline-2-carboxamides as serotonin(3) (5-HT3) receptor antagonist
по: Mahesh, R., и др.
Опубликовано: (2004)

The 5-HT2A receptor antagonist M100907 produces antiparkinsonian effects and decreases striatal glutamate
по: Twum eAnsah, и др.
Опубликовано: (2011-06-01)